Former National Institutes of Health Director Elias Zerhouni has joined the board of directors at Danaher. Zerhouni served as head of NIH between 2002 and 2008. During his tenure, he undertook the Roadmap for Medical Research, which aims to increase collaboration between NIH's 27 institutes and centers and to pursue innovative and important research areas. Zerhouni currently is a senior advisor at Johns Hopkins University School of Medicine and a senior fellow for the Bill and Melinda Gates Foundation's Global Health Program.
Affymetrix last week named Andrew Last to the position of chief commercial officer. Prior to joining Affymetrix, Last served on the leadership team of BD Biosciences' cell analysis unit, where he was vice president of global marketing and strategic planning and general manager of BD's San Diego-based Pharmingen business.